ATE242002T1 - Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose - Google Patents

Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose

Info

Publication number
ATE242002T1
ATE242002T1 AT00900306T AT00900306T ATE242002T1 AT E242002 T1 ATE242002 T1 AT E242002T1 AT 00900306 T AT00900306 T AT 00900306T AT 00900306 T AT00900306 T AT 00900306T AT E242002 T1 ATE242002 T1 AT E242002T1
Authority
AT
Austria
Prior art keywords
necrosis factor
tumor necrosis
use against
factor antagonists
against endometriosis
Prior art date
Application number
AT00900306T
Other languages
English (en)
Inventor
Francesco Borrelli
Antonio Mauro D
Fabrizio Martelli
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8237393&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE242002(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of ATE242002T1 publication Critical patent/ATE242002T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1793—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/30—Non-immunoglobulin-derived peptide or protein having an immunoglobulin constant or Fc region, or a fragment thereof, attached thereto

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00900306T 1999-01-22 2000-01-19 Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose ATE242002T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99101194A EP1022027A1 (de) 1999-01-22 1999-01-22 Antagonisten von Tumornecrosefaktor und ihre Verwendungen gegen Endometriose
PCT/IB2000/000052 WO2000043031A1 (en) 1999-01-22 2000-01-19 Tumor necrosis factor antagonists and their use in endometriosis

Publications (1)

Publication Number Publication Date
ATE242002T1 true ATE242002T1 (de) 2003-06-15

Family

ID=8237393

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00900306T ATE242002T1 (de) 1999-01-22 2000-01-19 Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose

Country Status (30)

Country Link
US (2) US6663865B1 (de)
EP (2) EP1022027A1 (de)
JP (1) JP4601176B2 (de)
KR (2) KR100685106B1 (de)
CN (2) CN1212152C (de)
AR (1) AR022251A1 (de)
AT (1) ATE242002T1 (de)
AU (1) AU771964B2 (de)
BG (1) BG65556B1 (de)
BR (1) BR0008182A (de)
CA (1) CA2356737C (de)
CZ (1) CZ302866B6 (de)
DE (1) DE60003152T2 (de)
DK (1) DK1143997T3 (de)
EA (1) EA003927B1 (de)
EE (1) EE05543B1 (de)
ES (1) ES2200808T3 (de)
HK (1) HK1043059B (de)
HU (1) HU226149B1 (de)
IL (2) IL144413A0 (de)
NO (1) NO328814B1 (de)
NZ (1) NZ512585A (de)
PL (1) PL204713B1 (de)
PT (1) PT1143997E (de)
SI (1) SI1143997T1 (de)
SK (1) SK287313B6 (de)
TR (1) TR200102107T2 (de)
UA (1) UA78483C2 (de)
WO (1) WO2000043031A1 (de)
ZA (1) ZA200105263B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL157024A0 (en) * 2001-01-29 2004-02-08 Applied Research Systems Il-18 inhibitors in heart disease
US20060073141A1 (en) * 2001-06-28 2006-04-06 Domantis Limited Compositions and methods for treating inflammatory disorders
US20050271663A1 (en) * 2001-06-28 2005-12-08 Domantis Limited Compositions and methods for treating inflammatory disorders
EP1709965A3 (de) 2001-07-11 2006-12-27 Boehringer Ingelheim Pharmaceuticals, Inc. Methode zur Behandlung von zytokinvermittelten Erkrankungen
US7082134B1 (en) * 2002-01-18 2006-07-25 Juniper Networks, Inc. Redirect checking in a network device
US20070298041A1 (en) * 2002-06-28 2007-12-27 Tomlinson Ian M Ligands That Enhance Endogenous Compounds
US9028822B2 (en) 2002-06-28 2015-05-12 Domantis Limited Antagonists against TNFR1 and methods of use therefor
AU2003212569A1 (en) * 2003-02-07 2004-08-30 Ambros Valentin Huber Use of human chorionic gonadotropin in the treatment in the treatment of symptoms caused by endometriosis
SG146624A1 (en) 2003-09-11 2008-10-30 Kemia Inc Cytokine inhibitors
GB0327112D0 (en) 2003-11-21 2003-12-24 Clincial Designs Ltd Dispenser and reservoir
GB0408449D0 (en) 2004-04-15 2004-05-19 Banerjee Subhasis Diagnostic and therapeutic applications of soluble lhcge protein
JP2008501035A (ja) * 2004-05-28 2008-01-17 アプライド リサーチ システムズ エーアールエス ホールディング ナームロゼ フェンノートシャップ 妊孕性関連障害の治療におけるｉｌ−１７の使用
US20060045902A1 (en) * 2004-09-01 2006-03-02 Serbousek Jon C Polymeric wrap for in vivo delivery of osteoinductive formulations
EP2462959B1 (de) * 2005-07-12 2016-06-22 Ampio Pharmaceuticals, Inc. Verfahren und Produkte zur Behandlung von Erkrankungen
CA2683801A1 (en) * 2007-06-06 2008-12-11 Domantis Limited Polypeptides, antibody variable domains and antagonists
SG177302A1 (en) * 2009-06-22 2012-02-28 Dmi Acquisition Corp Methods and products for treatment of diseases
SG2014008171A (en) 2009-06-22 2014-04-28 Ampio Pharmaceuticals Inc Method for treatment of diseases
SG11201504380SA (en) 2012-12-19 2015-07-30 Ampio Pharmaceuticals Inc Method for treatment of diseases
WO2016140921A1 (en) 2015-03-02 2016-09-09 180 Therapeutics Lp Method of treating a localized fibrotic disorder using an il-33 antagonist

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5037805A (en) * 1989-03-20 1991-08-06 The Salk Institute For Biological Studies Methods of contraception
DE07012626T1 (de) * 1991-03-18 2010-01-21 New York University Monoklonale und chimäre Antikörper gegen humanen Tumornekrosefaktor
US20040120952A1 (en) * 2000-08-07 2004-06-24 Centocor, Inc Anti-TNF antibodies and peptides of human tumor necrosis factor
NZ256293A (en) * 1992-09-15 1997-06-24 Immunex Corp Method of treating tumour necrosis factor - mediated inflammation by use of tnf antagonist
US5389657A (en) * 1993-02-01 1995-02-14 Free Radical Sciences Corporation Method for treating infertility
IL111125A0 (en) * 1994-05-11 1994-12-29 Yeda Res & Dev Soluble oligomeric tnf/ngf super family ligand receptors and their use
US5747532A (en) * 1995-11-21 1998-05-05 Medinox, Inc. Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor
US6090382A (en) * 1996-02-09 2000-07-18 Basf Aktiengesellschaft Human antibodies that bind human TNFα
US5710247A (en) * 1996-03-19 1998-01-20 Abbott Laboratories Process and intermediates for the synthesis of LHRH antagonists
GB9607120D0 (en) * 1996-04-04 1996-06-12 Chiroscience Ltd Compounds
GB9616643D0 (en) * 1996-08-08 1996-09-25 Chiroscience Ltd Compounds
AU7408998A (en) * 1996-11-27 1998-06-22 Immunex Corporation Method of regulating nitric oxide production
US6514977B1 (en) * 1997-05-22 2003-02-04 G.D. Searle & Company Substituted pyrazoles as p38 kinase inhibitors

Also Published As

Publication number Publication date
HU226149B1 (en) 2008-05-28
DK1143997T3 (da) 2003-09-15
US6663865B1 (en) 2003-12-16
HUP0105103A2 (hu) 2002-04-29
SI1143997T1 (en) 2003-12-31
KR100685106B1 (ko) 2007-02-22
AU771964B2 (en) 2004-04-08
BG105691A (en) 2002-02-28
SK10292001A3 (sk) 2001-12-03
SK287313B6 (sk) 2010-06-07
JP2002535284A (ja) 2002-10-22
US20040057954A1 (en) 2004-03-25
IL144413A (en) 2009-05-04
CZ302866B6 (cs) 2011-12-21
KR20010101397A (ko) 2001-11-14
DE60003152D1 (de) 2003-07-10
ES2200808T3 (es) 2004-03-16
AR022251A1 (es) 2002-09-04
NO20013577L (no) 2001-08-29
CN1212152C (zh) 2005-07-27
BG65556B1 (bg) 2008-12-30
CN1337883A (zh) 2002-02-27
EA200100799A1 (ru) 2001-12-24
EE05543B1 (et) 2012-06-15
CZ20012656A3 (cs) 2002-02-13
EE200100378A (et) 2002-10-15
TR200102107T2 (tr) 2001-12-21
HK1082690A1 (zh) 2006-06-16
EP1022027A1 (de) 2000-07-26
PL350002A1 (en) 2002-10-21
IL144413A0 (en) 2002-05-23
NO328814B1 (no) 2010-05-18
PT1143997E (pt) 2003-10-31
AU1997300A (en) 2000-08-07
JP4601176B2 (ja) 2010-12-22
BR0008182A (pt) 2001-11-06
NO20013577D0 (no) 2001-07-19
EP1143997B1 (de) 2003-06-04
HK1043059B (zh) 2005-11-18
CN100594932C (zh) 2010-03-24
HK1043059A1 (en) 2002-09-06
HUP0105103A3 (en) 2004-08-30
WO2000043031A1 (en) 2000-07-27
DE60003152T2 (de) 2004-03-25
EP1143997A1 (de) 2001-10-17
KR20060128056A (ko) 2006-12-13
UA78483C2 (en) 2007-04-10
CN1698894A (zh) 2005-11-23
CA2356737C (en) 2010-03-23
CA2356737A1 (en) 2000-07-27
ZA200105263B (en) 2002-06-26
NZ512585A (en) 2003-08-29
PL204713B1 (pl) 2010-02-26
EA003927B1 (ru) 2003-10-30

Similar Documents

Publication Publication Date Title
DE60003152D1 (de) Tumor nekrose faktor antagonisten und ihre verwendung gegen endometriose
DE60027479D1 (de) Harzstruktur und ihre verwendung
DE60106423D1 (de) Entzündungshemmende verbindungen und ihre verwendung
DE60016326D1 (de) Wasser-absorbierende Zusammensetzung und ihre Verwendung
DE60036803D1 (de) Arylmethyl-carbonylamino-thiazolderivate und ihre verwendung als antitumormittel
AU2003301662A8 (en) Quinazolinones and derivatives thereof as factor xa inhibitors
ATE533508T1 (de) Cripto-blockierende antikörper und ihre verwendung
ATE302193T1 (de) Benzoheterozyklen und ihre verwendung als mek inhibitoren
ATE376357T1 (de) Chinolin-; isochinolin- und chinazolinoxyalkylamide und ihre verwendung als fungizide
ATE424202T1 (de) Substituierte 2-thio-3,5-dicyano-4-phenyl-6- aminopyridine und ihre verwendung
ATE315554T1 (de) Diaminothiazole und ihre verwendung als cyclinabhängige kinase inhibitoren
DE60017894D1 (de) Diaminothiazole und ihre verwendung zur inhibierung von proteinkinasen
DE60027927D1 (de) Harzstruktur und ihre verwendung
ATE332294T1 (de) Dihydro-1,3,5-triazin-diamin-derivate und ihre therapeutische verwendung
DE60209486D1 (de) Pyranoindazole und ihre verwendung in der glaukombehandlung
DE60106607D1 (de) Substituierte 1-aminoalkyl-lactame und ihre verwendung als muscarinrezeptor antagonisten
ATE420642T1 (de) Neue formulierungen und ihre verwendung
ATE329906T1 (de) Substituierte 2-anilino-benzimidazole und ihre verwendung als nhe-inhibitoren
ATE419366T1 (de) Tyra-gene und ihre verwendung
DE60318733D1 (de) Substituierte benzoxazinones und ihre verwendung
ATE419248T1 (de) Phenylsubstituierte 4-hydroxy-tetrahydropyridone und ihre verwendung als schädlingsbekämpungsmittel und herbizide
DE50202730D1 (de) Substituierte isoindole und ihre verwendung
DE60030366D1 (de) Flexible Harzzusammensetzung und ihre Verwendung
DE50008427D1 (de) Lumineszierende 4-trifluormethyl-2-chinolinone mit langwelliger uv-absorption und ihre verwendung
DE60101245D1 (de) Beschichtungszusammensetzung und ihre Verwendung

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1143997

Country of ref document: EP

EEFA Change of the company name